Effects of pregnenolone, cyanoketone, and equilenin on the human malignant trophoblast in vitro.
D015068:17-Ketosteroids / Q000494:pharmacology*; D000737:Androstenols / Q000494:pharmacology*; D002460:Cell Line; D006063:Chorionic Gonadotropin / Q000378:metabolism; D003489:Cyanoketone / Q000494:pharmacology*; D004855:Equilenin / Q000494:pharmacology*; D004964:Estriol / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D009363:Neoplasm Proteins / Q000378:metabolism; D011284:Pregnenolone / Q000378:metabolism / Q000494:pharmacology*; D013936:Thymidine / Q000378:metabolism; D014327:Trophoblasts / Q000187:drug effects* / Q000378:metabolism
D015068:17-Ketosteroids; D000737:Androstenols; D006063:Chorionic Gonadotropin; D009363:Neoplasm Proteins; D003489:Cyanoketone; D011284:Pregnenolone; D006003:Glycogen; D004964:Estriol; D005947:Glucose; D013936:Thymidine; D004855:Equilenin